Pfizer Inc. Canadian Depositary Receipt Logo

Pfizer Inc. Canadian Depositary Receipt (PFE)

TSX

Currency in CAD
12.72
+0.26 (+2.09%)

Closed

Aug 25, 2026

Day's Range

12.40
12.73

52 wk Range

10.57
12.92

Overview - PFE - Pfizer Inc. Canadian Depositary Receipt

Key Statistics

Valuation

Enterprise Value

284.03B

P/E (Trailing)

‪35.33‬

PEG Ratio

‪-0.32‬

Price / Sales (TTM)

‪3.53‬

Price / Book

‪2.49‬

EV / EBITDA

‪11.03‬

Profitability

Gross Margin

‪72.78%‬

Profit Margin

‪74.32%‬

Operating Margin

‪16.28%‬

Return on Assets

‪3.73%‬

Return on Equity

‪8.95%‬

Ownership

Shares Outstanding

5.69B

Price stats

50-Day Avg

‪11.36‬

200-Day Avg

‪11.75‬

Dividends

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - PFE - Pfizer Inc. Canadian Depositary Receipt

Peers - PFE - Pfizer Inc. Canadian Depositary Receipt

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on TSX.

Profile Summary - PFE - Pfizer Inc. Canadian Depositary Receipt

About

Pfizer Inc. Canadian Depositary Receipt is an equity security that provides Canadian investors with fractional economic exposure to Pfizer Inc., one of the world’s largest research‑based pharmaceutical companies. The receipt represents an interest in Pfizer shares while trading in Canadian dollars, with a built‑in…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees75K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.